Life insurance: two statements, and why profit arrives decades late

A life insurer writes a flood of new policies, grows its new-business premium 30%, and creates a vast amount of value for its owners. And its reported profit after tax falls. Not despite the growth — because of it. The faster it sells, the worse its bottom line looks in the year it sells, and a reader watching that bottom line would conclude the business is struggling at the exact moment it is winning. illustrative

This is not an accounting quirk to be waved away; it is the defining feature of how life insurance works. When an insurer sells a twenty-year policy, it incurs the cost of that sale now — the commission, the underwriting, the reserves it must set up — but it earns the profit slowly, over the two decades the policyholder keeps paying. So the reported profit in any one year is a strange, lagging thing: it reflects the slow emergence of profits from policies sold long ago, minus the up-front strain of policies sold this year. Grow fast and the strain dominates. The profit-and-loss account, the number every other business is judged on, is close to the least useful figure in a life insurer's accounts.

Which means you have to read a completely different set of numbers. The value a life insurer creates is captured the day a policy is sold, in the value of new business. The total worth of the book is captured in the embedded value. And whether that value is real or illusory is captured in persistency — whether the policyholders actually keep paying. This module reads a business where profit arrives decades late, and where the whole skill is learning to see the value the reported profit hides.

Module 6 taught that profit is an opinion. Life insurance is the extreme case, where the reported profit is not merely an opinion but a genuinely poor measure of the year's economics, and a different framework is required to see the business at all. This module exists because a reader who brings a manufacturer's or even a bank's instincts to a life insurer will misread it completely — rewarding low growth, punishing high growth, and mistaking the up-front cost of value creation for a loss.

Three ideas replace reported profit. Value of new business, or VNB, is the present value of the future profits expected from the policies written this year — it captures, up front, the value that the P&L will only reveal over the following two decades. Embedded value is the insurer's net worth plus the present value of the profits locked into its entire existing book — the best single measure of what the business is worth today. And persistency is the share of policyholders still paying their premiums after 13, 25, 37, 49 and 61 months — the honesty check on everything else, because a policy that lapses never delivers the value VNB assumed.

There is also the two-statement structure to hold onto. A life insurer files a Revenue Account, which belongs to the policyholders and holds the vast pool of premiums, investments and reserves, and a Profit and Loss Account, which belongs to the shareholders and receives a small surplus transferred from the policyholders' fund. Reading only the shareholders' P&L — the natural instinct, since that is where "profit" lives — tells you almost nothing about the business, because the business is in the policyholders' account and in the VNB and embedded-value disclosures alongside it. Without this module, an investor reads the wrong statement and the wrong line, and reaches a confident conclusion about a business they have not actually looked at.

Begin with the gap between what the P&L reports and what the business creates.

The two statements. The Revenue Account is the policyholders' fund — premiums in, investment income on the pool, benefits and claims paid out, and the enormous change in policy reserves as future obligations are set aside. This is where the business physically happens, and it dwarfs the shareholders' account. The Profit and Loss Account is the shareholders' fund, and its main input is a surplus transferred out of the policyholders' account each year, actuarially determined — computed by an actuary, the specialist who prices insurance risk and sets its reserves. The reported profit after tax sits here — and it is small, lagging, and shaped by how much surplus the actuary released, not by how good the year was.

New business strain, and why profit emerges late. When a policy is sold, the insurer pays commission and underwriting costs and must set up reserves against the promise it has made — all now. The profit on that policy emerges only as the years pass and the premiums keep coming. So each new policy is a cost this year and a stream of profit for twenty years. In a fast-growing year, the strain from all the new policies weighs on reported profit while the emergence from old policies has not yet caught up — which is exactly why growth suppresses the bottom line.

VNB and embedded value capture now what the P&L reveals later. Rather than wait two decades to see whether a policy was worthwhile, actuaries compute its value up front: the value of new business is the present value of all the future profit expected from this year's sales, net of the strain. Sum the same calculation over the entire in-force book — every policy still active and paying — and add the net worth, and you get embedded value — the worth of the business today. Growth in embedded value, driven mainly by VNB plus the unwinding of prior years' value — last year's expected future profit moving one year closer, and so counted now — is the closest thing a life insurer has to a real annual profit, and it can be several times the reported figure.

Persistency is the honesty check. All of this rests on an assumption: that policyholders keep paying. Persistency measures whether they do — the percentage still active after 13 months, and further out at 61 months. High persistency means the VNB was earned honestly, on policies people wanted. Low persistency means policies were sold that quickly lapse, so the VNB booked up front will never actually be realised. It is the single number that tells you whether the value the insurer reports is genuine or a projection that will quietly evaporate.

The idea that reported profit measures the year's success is true for most businesses and structurally false for a life insurer. Set it beside its neighbours to see how far it inverts.

The inversion to hold is that for a life insurer, reported profit and business success can point in opposite directions. A manufacturer that grows fast and profitably shows a rising profit; a life insurer that grows fast and profitably shows a falling one, because the value it created is deferred while the cost of creating it is immediate. This is not a subtle difference of emphasis — it is a sign reversal. An investor who ranks life insurers by their price-to-earnings multiple (the share price divided by annual profit), as they would a manufacturer, is using a denominator that actively misleads, and will systematically prefer the slow-growing insurer to the fast-growing one. The right multiples here are price-to-embedded-value and price-to-VNB, because those are the numbers that measure what the business actually did.

Read the composite life insurer's fifth year. The shareholders' Profit and Loss Account reports a profit after tax of ₹1,930 crore. Taken alone, on a business with an embedded value of ₹47,000 crore, that looks like a thin return — barely 4% on the embedded value, worse than a fixed deposit. If you valued this insurer on its reported earnings, you would call it a poor business. illustrative

Now read what it actually did. The value of new business written this year was ₹3,980 crore — more than double the reported profit — at a VNB margin of 26%, up from 22% five years ago, so each rupee of new premium is creating more value than before. The embedded value grew from ₹39,500 crore to ₹47,000 crore, a gain of ₹7,500 crore — nearly four times the reported profit — at an operating return on embedded value of 19%. That 19% is the real return the business earned on its worth, and it is excellent. The reported ₹1,930 crore was never the point; it was the small surplus the actuary chose to transfer to shareholders while the bulk of the value stayed locked in the policyholders' fund, emerging over decades.

Then check the honesty of it all through persistency. Thirteen-month persistency is 88% and rising, and 61-month persistency is 58% — meaning most policyholders keep paying in the crucial first year and well over half are still paying after five. That is a genuinely sold book, not a churned one, so the VNB the insurer booked will largely be realised. The product mix is tilting toward protection (21% and rising) — protection here meaning pure life-cover policies, with no savings element — the highest-margin, stickiest business. Every real metric says this is a strong, improving insurer — and the one number that says otherwise is the reported profit.

The habit to build: for a life insurer, ignore the reported profit and the P/E almost entirely. Read VNB and the VNB margin to see the value written this year and whether it is improving; read embedded value and its operating return to see the worth of the book and the return on it; and read persistency across the durations to check that the value is real and not lapsing away. Value the insurer on embedded value and VNB, never on earnings. A life insurer is the clearest case in the whole market where the reported profit is not just imperfect but pointed the wrong way.

Increase the amount of new business the insurer writes this year and watch two numbers move in opposite directions: this year's reported profit falls under new-business strain — the upfront cost of writing and reserving a policy — while the value of new business rises, because each policy sold is worth a stream of future profit. The accounting profit and the economic value disagree, which is exactly why a life insurer is judged on value of new business and embedded value, not on the current-year P&L.

Embedded value and VNB are actuarial calculations, and they are only as good as the assumptions inside them. They project decades of persistency, mortality, expenses and investment returns, and management chooses those assumptions within a defensible range. An insurer that assumes slightly better persistency or slightly lower future expenses reports a higher VNB and embedded value with no change in the actual business — the same judgement lever that inflates a manufacturer's profit, moved into the actuarial model. The reported VNB is a genuine improvement on reported profit as a measure, but it is not an observed fact; it is a projection, and the sensitivity of that projection to its assumptions is disclosed for a reason.

Nor does the embedded value tell you what will happen to the assumptions themselves. A book valued on 88% persistency is worth far less if a change in tax treatment, a mis-selling scandal, or a shift in the savings market pushes persistency down. Embedded value captures the value of the in-force book under today's assumptions; it does not price the risk that those assumptions deteriorate. The value is real but conditional, and the conditions — regulation, competition, distribution economics — sit outside the number and have to be judged separately.

And the life-insurance framework, for all its sophistication, cannot make the reported profit meaningful — it can only route around it. That has a cost: the numbers that matter are actuarial, disclosed less frequently, and harder for an outsider to verify than a manufacturer's cash flow. You are trusting the actuary and the auditor to a greater degree than in almost any other sector, because the value is inherently a projection of the future rather than a record of the past. Persistency and the sensitivity disclosures are the main external checks, and beyond them the reader has less independent ground to stand on than usual — a limitation worth holding consciously rather than forgetting behind the elegance of embedded value.

How it comes up. With a life insurer, a sharp analyst pushes on the assumptions behind the value, because that is where the reported strength is either earned or manufactured. The question sounds like this: "VNB margin rose 400 basis points over three years. How much of that is genuine mix shift toward protection, and how much is changes in your persistency and expense assumptions? And what's the embedded-value sensitivity to a 10% fall in persistency?" The analyst is separating a real improvement from a re-assumed one.

A good answer, verbatim-style.

"Of the 400 basis points, about 300 is genuine mix — protection went from 14% to 21% of new business, and it carries a far higher margin. Roughly 100 is a persistency assumption update, which we made because actual 13-month persistency has run at 87-88% for three years against the 85% we'd assumed, so it's catching up to reality, not getting ahead of it. On sensitivity, a 10% relative fall in persistency would reduce embedded value by about 4%, and we disclose the full sensitivity table on page 240. So most of the margin gain is mix, and the assumption change is backward-looking, not aggressive."

It splits the improvement into real mix and re-assumption, justifies the assumption change against actual experience, and gives the sensitivity with a source. It lets you judge how much of the reported value is earned.

An evasive answer, verbatim-style.

"We're delighted with our VNB margin expansion, which reflects our disciplined focus on high-quality, high-margin business and the strength of our multi-channel distribution. Our embedded value continues to compound at industry-leading rates, and our actuarial assumptions are prudent and reviewed regularly by our appointed actuary and the board. We're confident in the sustainability of our value creation."

Confident and unfalsifiable. It never splits the margin gain into mix versus assumption changes, never gives a persistency figure, and offers no embedded-value sensitivity. "Prudent assumptions, reviewed regularly" is exactly what an insurer inflating its VNB through optimistic assumptions would also say, and "industry-leading compounding" is a boast, not the decomposition the question asked for.

The follow-up nobody asks. "If you held all actuarial assumptions flat at last year's, what would VNB margin and embedded value be this year?" That strips out the re-assumption and shows the underlying business alone. Watch what happens when it is not asked. If "prudent, reviewed regularly" is allowed to stand, an investor capitalises an assumption change as if it were operating performance. The silence is the tell — either the assumption changes are doing more of the work than management wants to admit, or the persistency and expense experience behind them would not survive the question.

The first trap is judging a life insurer on its reported profit or its price-to-earnings multiple, exactly as one would a normal company. Because profit emerges over decades and fast growth brings up-front strain, the reported profit is a lagging, near-useless number, and ranking insurers by their P/E systematically rewards the slow-growing one and punishes the fast-growing one — the reverse of the truth. The insurer creating the most value can show the lowest reported profit. The right lenses are embedded value and VNB, and reaching for earnings out of habit is the single most common error in the sector.

The second trap is reading premium growth as value growth. A life insurer can grow its premium rapidly by pushing low-margin, single-premium market-linked products that lapse quickly, booking impressive top-line numbers while creating little embedded value and leaving a book that churns. Growth in premium is not the same as growth in VNB, and VNB is not realised unless persistency holds. An insurer growing premium with a thin VNB margin and falling persistency is manufacturing the appearance of a good year, and the value it reports up front will quietly evaporate as the policies lapse.

The third trap is treating embedded value as a hard number rather than a projection. It is a far better measure than reported profit, but it is built on actuarial assumptions about persistency, expenses, mortality and investment returns, all chosen by management within a range. A rising embedded value driven by genuine mix shift and honest experience is real; a rising embedded value driven by quietly optimistic assumption changes is the same profit-flattering lever seen everywhere else, moved into a model most readers cannot audit. The check is to ask how much of the growth came from the business and how much from re-assumption, and to read the persistency experience and the sensitivity tables — because an embedded value taken on faith is exactly where a life insurer's story can be dressed up.